Search results
Is BridgeBio Pharma (BBIO) Stock Outpacing Its Medical Peers This Year?
Zacks via Yahoo Finance· 1 year agoInvestors interested in Medical stocks should always be looking to find the best-performing...
BridgeBio Pharma (BBIO) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks via Yahoo Finance· 8 months agoBridgeBio Pharma (BBIO) possesses the right combination of the two key ingredients for a likely...
Does BridgeBio Pharma (BBIO) Have the Potential to Rally 67.36% as Wall Street Analysts Expect?
Zacks via Yahoo Finance· 1 year agoThe consensus price target hints at a 67.4% upside potential for BridgeBio Pharma (BBIO). While...
Why BridgeBio's Battle With Pfizer In Heart Disease Treatment Is Just Heating Up
Investor's Business Daily· 10 months agoShares of BBIO stock slumped Monday, reversing a premarket gain, as analysts parsed through...
Shareholders in BridgeBio Pharma (NASDAQ:BBIO) have lost 85%, as stock drops 15% this past week
Simply Wall St. via Yahoo Finance· 2 years agoBridgeBio Pharma, Inc. (NASDAQ:BBIO) shareholders will doubtless be very grateful to see the share...
BridgeBio Pharma (BBIO) Moves 9.7% Higher: Will This Strength Last?
Zacks via Yahoo Finance· 1 year agoBridgeBio Pharma (BBIO) witnessed a jump in share price last session on above-average trading...
BridgeBio Pharma (NASDAQ:BBIO investor three-year losses grow to 81% as the stock sheds US$120m this...
Simply Wall St. via Yahoo Finance· 2 years agoIt's not possible to invest over long periods without making some bad investments. But really big...
BridgeBio Soars 52% And Breaks Out After Smashing Expectations In A Dwarfism Study
Investor's Business Daily· 1 year agoBridgeBio Pharma smashed Wall Street's expectations in a study of children with dwarfism, leading...
Biotech Stock Roundup: BBIO, ARGX Soar on Study Results, APLS Down on Safety Issues
Zacks via Yahoo Finance· 11 months agoIt was a busy week for the biotech sector, with many important regulatory and pipeline updates....
BridgeBio Launches 76% And Pulls Its Rival Higher On Bullish Heart Drug News
Investor's Business Daily· 11 months agoBridgeBio Pharma scored a "best-case scenario" for its heart-disease drug on Monday and BBIO stock...